156 related articles for article (PubMed ID: 23408368)
1. Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.
Fan S; Meng D; Xu T; Chen Y; Wang J; Li X; Chen H; Lu D; Chen J; Lan Q
Med Oncol; 2013 Mar; 30(1):384. PubMed ID: 23408368
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CD147 in patients with glioblastoma.
Yang M; Yuan Y; Zhang H; Yan M; Wang S; Feng F; Ji P; Li Y; Li B; Gao G; Zhao J; Wang L
J Neurooncol; 2013 Oct; 115(1):19-26. PubMed ID: 23925827
[TBL] [Abstract][Full Text] [Related]
3. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
[TBL] [Abstract][Full Text] [Related]
4. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
5. FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patients.
Wang Y; Cai R; Wang P; Huang C; Zhang C; Liu Z
Clin Neurol Neurosurg; 2021 Feb; 201():106421. PubMed ID: 33370626
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.
Freitas M; Malheiros S; Stávale JN; Biassi TP; Zamunér FT; de Souza Begnami M; Soares FA; Vettore AL
Oncotarget; 2013 Apr; 4(4):636-46. PubMed ID: 23592437
[TBL] [Abstract][Full Text] [Related]
7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
9. The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma.
Chang L; Zhang P; Zhao D; Liu H; Wang Q; Li C; Du W; Liu X; Zhang H; Zhang Z; Jiang C
Tumour Biol; 2016 Mar; 37(3):3979-86. PubMed ID: 26482617
[TBL] [Abstract][Full Text] [Related]
10. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
[TBL] [Abstract][Full Text] [Related]
11. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
[TBL] [Abstract][Full Text] [Related]
12. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
Liu B; Liu J; Liao Y; Jin C; Zhang Z; Zhao J; Liu K; Huang H; Cao H; Cheng Q
Med Sci Monit; 2019 May; 25():3624-3635. PubMed ID: 31094363
[TBL] [Abstract][Full Text] [Related]
13. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
Chen J; Yang L; Wang X
Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
[TBL] [Abstract][Full Text] [Related]
14. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
[TBL] [Abstract][Full Text] [Related]
15. SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.
Yan Y; Zhang L; Xu T; Zhou J; Qin R; Chen C; Zou Y; Fu D; Hu G; Chen J; Lu Y
PLoS One; 2013; 8(11):e81905. PubMed ID: 24278465
[TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p.
Jiang G; Dong H; Dong Y; Yang X
Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
18. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis and verification of molecular genetic targets for glioblastoma.
Xue L; Liu H; Chen Y; Wei L; Hong J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
[TBL] [Abstract][Full Text] [Related]
20. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]